Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
Medical Science Monitor · 2024
DOI: 10.12659/msm.943750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2024. Verfasst von Mustafa Karaca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND Pathologic response after neoadjuvant therapy has been shown to improve outcomes in rectal cancer. Inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), have been studied to predict pathologic response and survival. This study aimed to evaluate the association between NLR and pathological response as well as outcome in patients with rectal cancer who underwent neoadjuvant chemoradiotherapy (nCRT). MATERIAL AND METHODS We retrospectively analyzed 187 patients with rectal cancer treated with nCRT followed by surgery between 2016 and 2020. The NLR was calculated using archival complete blood count records. Postoperative pathology reports were recorded. The NLR cut-off was determined by receiver operating characteristic curve. Kaplan-Meier survival curves and univariate and multivariate Cox regression analyses were used to analyze the relationship between NLR and clinicopathologic data to predict survival and prognosis. RESULTS An NLR >3.63 at diagnosis was the optimal cut-off value for predicting progression. Near-complete response rates were higher in patients with NLR 3.63 (18%) (P=0.035). The NLR 3.63 group (63.6% vs 40.1%, respectively; P=0.007). The NLR 3.63 group (72.3% vs 63.1%, respectively), but the difference was not statistically significant (P=0.077). CONCLUSIONS Our study showed a higher near-complete response rate in rectal cancer patients with NLR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
- Department of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey.
- Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.
ORCID-Profile: Mustafa Karaca, Mustafa Serkan Alemdar, Özge Deniz Karaca, Mustafa Özgür Arıcı
Zitieren
APA
Karaca, M., Salim, E., Alemdar, M. S., Deniz Karaca, Ö., & Arıcı, M. Ö. (2024). Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Medical Science Monitor. https://doi.org/10.12659/msm.943750
Vancouver
Karaca M, Salim E, Alemdar MS, Deniz Karaca Ö, Arıcı MÖ. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Medical Science Monitor. 2024. doi:10.12659/msm.943750
BibTeX
@article{Karaca2024,
author = {Karaca, Mustafa and Salim, Ece and Alemdar, Mustafa Serkan and Deniz Karaca, Özge and Arıcı, Mustafa Özgür},
title = {Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy},
journal = {Medical Science Monitor},
year = {2024},
doi = {10.12659/msm.943750}
}
EUVIMED